Clinical Trials Browser

Phase 2 × Urogenital Diseases × Genitourinary × Clear all

NCT07457164 2026-03-12

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

Phase 2 Not yet recruiting

40 enrolled

Genitourinary

Urogenital Diseases, Prostatic Diseases

NCT06237920 2025-09-03

TURANDORELA

Phase 2 Recruiting

90 enrolled

Genitourinary

Urogenital Diseases, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Neoplasms, Female Urogenital Diseases, Male Urogenital Diseases

NCT03081884 2021-01-25

EDRN-FACBC

Phase 2 Completed

61 enrolled 6 charts

Genitourinary

Urogenital Diseases, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT02830880 2020-01-07

FACBC Prostate Therapy Response

Phase 2 Completed

7 enrolled 10 charts

Genitourinary

Urogenital Diseases, Neoplasms, Prostatic Neoplasms